BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: O’Brien CJ, McNeil EB, McMahon JD, Pathak I, Lauer CS, Jackson MA. Significance of clinical stage, extent of surgery, and pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland. Head Neck. 2002;24:417-422. [PMID: 12001070 DOI: 10.1002/hed.10063] [Cited by in Crossref: 187] [Cited by in F6Publishing: 160] [Article Influence: 9.8] [Reference Citation Analysis]
Number Citing Articles
1 Myers LL, Ahn C. Cutaneous squamous cell carcinoma metastasis to the parotid region lymph nodes: Skin Cancer Metastasis to Parotid Region. The Laryngoscope 2019;129:1579-86. [DOI: 10.1002/lary.27534] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
2 Turner SJ, Morgan GJ, Palme CE, Veness MJ. Metastatic cutaneous squamous cell carcinoma of the external ear: a high-risk cutaneous subsite. J Laryngol Otol 2010;124:26-31. [DOI: 10.1017/s0022215109991101] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
3 Wong WK, Shetty S. Classification of parotidectomy: a proposed modification to the European Salivary Gland Society classification system. Eur Arch Otorhinolaryngol 2017;274:3175-81. [DOI: 10.1007/s00405-017-4581-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Beydoun N, Graham PH, Browne L. Metastatic Cutaneous Squamous Cell Carcinoma to the Axilla: A Review of Patient Outcomes and Implications for Future Practice. World J Oncol 2012;3:217-26. [PMID: 29147309 DOI: 10.4021/wjon503w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
5 Wierzbicka M, Kopeć T, Szyfter W, Kereiakes T, Bem G. The presence of facial nerve weakness on diagnosis of a parotid gland malignant process. Eur Arch Otorhinolaryngol 2012;269:1177-82. [PMID: 22179671 DOI: 10.1007/s00405-011-1882-6] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
6 Bachar G, Mizrachi A, Rabinovics N, Guttman D, Shpitzer T, Ad-el D, Hadar T. Prognostic Factors in Metastatic Cutaneous Squamous Cell Carcinoma of the Head and Neck. Ear Nose Throat J 2016;95:1-10. [DOI: 10.1177/0145561316095010-1106] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Olsen KD, Moore EJ. Deep lobe parotidectomy: clinical rationale in the management of primary and metastatic cancer. Eur Arch Otorhinolaryngol 2014;271:1181-5. [PMID: 23832259 DOI: 10.1007/s00405-013-2616-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
8 Tanvetyanon T, Padhya T, McCaffrey J, Kish JA, Deconti RC, Trotti A, Rao NG. Postoperative concurrent chemotherapy and radiotherapy for high-risk cutaneous squamous cell carcinoma of the head and neck. Head Neck 2015;37:840-5. [PMID: 24623654 DOI: 10.1002/hed.23684] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 7.3] [Reference Citation Analysis]
9 Stratigos AJ, Garbe C, Dessinioti C, Lebbe C, Bataille V, Bastholt L, Dreno B, Concetta Fargnoli M, Forsea AM, Frenard C, Harwood CA, Hauschild A, Hoeller C, Kandolf-Sekulovic L, Kaufmann R, Kelleners-Smeets NWJ, Malvehy J, Del Marmol V, Middleton MR, Moreno-Ramirez D, Pellecani G, Peris K, Saiag P, van den Beuken-van Everdingen MHJ, Vieira R, Zalaudek I, Eggermont AMM, Grob JJ; European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO) and the European Organization for Research and Treatment of Cancer (EORTC). European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment. Eur J Cancer 2020;128:83-102. [PMID: 32113942 DOI: 10.1016/j.ejca.2020.01.008] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 32.0] [Reference Citation Analysis]
10 Patel MJ, Liégeois NJ. Skin Cancer and the Solid Organ Transplant Recipient. Curr Treat Options in Oncol 2008;9:251-8. [DOI: 10.1007/s11864-008-0082-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
11 Harris BN, Pipkorn P, Nguyen KNB, Jackson RS, Rao S, Moore MG, Farwell DG, Bewley AF. Association of Adjuvant Radiation Therapy With Survival in Patients With Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck. JAMA Otolaryngol Head Neck Surg 2019;145:153-8. [PMID: 30570645 DOI: 10.1001/jamaoto.2018.3650] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 19.0] [Reference Citation Analysis]
12 Devaney KO, Rinaldo A, Rodrigo JP, Ferlito A. Sentinel node biopsy and head and neck tumors—Where do we stand today? Head Neck 2006;28:1122-31. [DOI: 10.1002/hed.20443] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
13 Gidley PW, Thompson CR, Roberts DB, Weber RS. The results of temporal bone surgery for advanced or recurrent tumors of the parotid gland: Temporal Bone Surgery for Parotid Tumor. The Laryngoscope 2011;121:1702-7. [DOI: 10.1002/lary.21867] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
14 Kolk A, Wolff KD, Smeets R, Kesting M, Hein R, Eckert AW. Melanotic and non-melanotic malignancies of the face and external ear - A review of current treatment concepts and future options. Cancer Treat Rev 2014;40:819-37. [PMID: 24814015 DOI: 10.1016/j.ctrv.2014.04.002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
15 Coombs AC, Butler A, Allison R. Metastatic cutaneous squamous cell carcinoma of the parotid gland: prognostic factors. J Laryngol Otol 2018;132:264-9. [DOI: 10.1017/s0022215117001323] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 2.8] [Reference Citation Analysis]
16 Olsen KD, Quer M, de Bree R, Vander Poorten V, Rinaldo A, Ferlito A. Deep lobe parotidectomy—why, when, and how? Eur Arch Otorhinolaryngol 2017;274:4073-8. [DOI: 10.1007/s00405-017-4767-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
17 Strom T, Harrison LB. Radiotherapy for management of basal and squamous cell carcinoma. Curr Probl Cancer 2015;39:237-47. [PMID: 26364698 DOI: 10.1016/j.currproblcancer.2015.07.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
18 Warner CL, Cockerell CJ. The new seventh edition American Joint Committee on Cancer staging of cutaneous non-melanoma skin cancer: a critical review. Am J Clin Dermatol 2011;12:147-54. [PMID: 21469759 DOI: 10.2165/11539420-000000000-00000] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
19 Bron LP, Traynor SJ, Mcneil EB, O???brien CJ. Primary and Metastatic Cancer of the Parotid: Comparison of Clinical Behavior in 232 Cases: . The Laryngoscope 2003;113:1070-5. [DOI: 10.1097/00005537-200306000-00029] [Cited by in Crossref: 113] [Cited by in F6Publishing: 81] [Article Influence: 6.3] [Reference Citation Analysis]
20 Feng Y, Liu F, Cheng G, Fang Q, Niu X, He W. Significance of intraparotid node metastasis in predicting local control in primary parotid cancer. The Laryngoscope 2018;129:2309-12. [DOI: 10.1002/lary.27701] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
21 Forest V, Clark JJ, Veness MJ, Milross C. N1S3: A revised staging system for head and neck cutaneous squamous cell carcinoma with lymph node metastases: Results of 2 Australian Cancer Centers. Cancer 2010;116:1298-304. [DOI: 10.1002/cncr.24855] [Cited by in Crossref: 70] [Cited by in F6Publishing: 63] [Article Influence: 6.4] [Reference Citation Analysis]
22 Kreinbrink PJ, Mierzwa ML, Huth B, Redmond KP, Wise-Draper TM, Casper K, Li J, Takiar V. Adjuvant radiation and cetuximab improves local control in head and neck cutaneous squamous cell carcinoma: A phase II study. Head Neck 2021. [PMID: 34363266 DOI: 10.1002/hed.26835] [Reference Citation Analysis]
23 Amoils M, Lee CS, Sunwoo J, Aasi SZ, Hara W, Kim J, Sirjani D, Colevas AD, Chang ALS, Divi V. Node-positive cutaneous squamous cell carcinoma of the head and neck: Survival, high-risk features, and adjuvant chemoradiotherapy outcomes: Regionally metastatic cutaneous HNSCC. Head Neck 2017;39:881-5. [DOI: 10.1002/hed.24692] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 7.0] [Reference Citation Analysis]
24 Oddone N, Morgan GJ, Palme CE, Perera L, Shannon J, Wong E, Gebski V, Veness MJ. Metastatic cutaneous squamous cell carcinoma of the head and neck: The Immunosuppression, Treatment, Extranodal spread, and Margin status (ITEM) prognostic score to predict outcome and the need to improve survival. Cancer 2009;115:1883-91. [DOI: 10.1002/cncr.24208] [Cited by in Crossref: 87] [Cited by in F6Publishing: 80] [Article Influence: 7.3] [Reference Citation Analysis]
25 Mooney CP, Clark JR, Shannon K, Palme CE, Ebrahimi A, Gao K, Ch'ng S, Elliott M, Gupta R, Low TH. The significance of regional metastasis location in head and neck cutaneous squamous cell carcinoma. Head Neck 2021;43:2705-11. [PMID: 34019319 DOI: 10.1002/hed.26744] [Reference Citation Analysis]
26 Ch'ng S, Maitra A, Lea R, Brasch H, Tan ST. Parotid metastasis--an independent prognostic factor for head and neck cutaneous squamous cell carcinoma. J Plast Reconstr Aesthet Surg 2006;59:1288-93. [PMID: 17113505 DOI: 10.1016/j.bjps.2006.03.043] [Cited by in Crossref: 57] [Cited by in F6Publishing: 44] [Article Influence: 3.8] [Reference Citation Analysis]
27 Cheng G, Liu F, Niu X, Fang Q. Role of the pretreatment neutrophil-to-lymphocyte ratio in the survival of primary parotid cancer patients. Cancer Manag Res 2019;11:2281-6. [PMID: 30962717 DOI: 10.2147/CMAR.S195413] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
28 Barzilai G, Greenberg E, Cohen-kerem R, Doweck I. Pattern of regional metastases from cutaneous squamous cell carcinoma of the head and neck. Otolaryngol Head Neck Surg 2005;132:852-6. [DOI: 10.1016/j.otohns.2005.01.036] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 4.4] [Reference Citation Analysis]
29 Schmidt C, Martin JM, Khoo E, Plank A, Grigg R. Outcomes of nodal metastatic cutaneous squamous cell carcinoma of the head and neck treated in a regional center. Head Neck 2015;37:1808-15. [PMID: 24995842 DOI: 10.1002/hed.23843] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
30 Cañueto J, Jaka A, Toll A. The Value of Adjuvant Radiotherapy in Cutaneous Squamous Cell Carcinoma: A Review. Actas Dermosifiliogr (Engl Ed) 2018;109:476-84. [PMID: 29759308 DOI: 10.1016/j.ad.2018.03.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
31 Sun J, Li B, Li CJ, Li Y, Su F, Gao QH, Wu FL, Yu T, Wu L, Li LJ. Computed tomography versus magnetic resonance imaging for diagnosing cervical lymph node metastasis of head and neck cancer: a systematic review and meta-analysis. Onco Targets Ther 2015;8:1291-313. [PMID: 26089682 DOI: 10.2147/OTT.S73924] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
32 Fishbach S, Steinhardt G, Zhen CJ, Puranik R, Segal JP, Cipriani NA. High Rates of Ultraviolet-Signature Mutations in Squamous Cell Carcinomas of the Parotid Gland and Prognostic Implications. Head Neck Pathol 2021. [PMID: 34160783 DOI: 10.1007/s12105-021-01349-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Withrow KP, Gleysteen JP, Safavy A, Skipper J, Desmond RA, Zinn K, Rosenthal EL. Assessment of indocyanine green–labeled cetuximab to detect xenografted head and neck cancer cell lines. Otolaryngol Head Neck Surg 2007;137:729-34. [DOI: 10.1016/j.otohns.2007.06.736] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
34 Shao A, Wong DKC, Mcivor NP, Mylnarek AM, Chaplin JM, Izzard ME, Patel RS, Morton RP. Parotid metastatic disease from cutaneous squamous cell carcinoma: Prognostic role of facial nerve sacrifice, lateral temporal bone resection, immune status and P-stage: Parotid Metastatic Disease from Cutaneous SCC. Head Neck 2014;36:545-50. [DOI: 10.1002/hed.23323] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
35 Wilkie MD, Chudek DA, Flynn CD, Gaskell P, Loh C, Tandon S, Roland NJ, Jones TM, Lancaster J. Outcomes and prognosticators in regionally recurrent cutaneous squamous cell carcinoma of the head and neck. Eur J Surg Oncol 2020;46:2035-41. [PMID: 32800595 DOI: 10.1016/j.ejso.2020.07.035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Badlani J, Gupta R, Smith J, Ashford B, Ch'ng S, Veness M, Clark J. Metastases to the parotid gland - A review of the clinicopathological evolution, molecular mechanisms and management. Surgical Oncology 2018;27:44-53. [DOI: 10.1016/j.suronc.2017.11.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
37 Ebrahimi A, Clark JR, Lorincz BB, Milross CG, Veness MJ. Metastatic head and neck cutaneous squamous cell carcinoma: Defining a low-risk patient. Head Neck 2012;34:365-70. [DOI: 10.1002/hed.21743] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 4.1] [Reference Citation Analysis]
38 Bowe CM, Gurney B, Whitaker S, Newlands C. Management of regional metastatic disease in cutaneous malignancy of the head and neck. 3. Merkel cell carcinoma. Br J Oral Maxillofac Surg 2019;57:847-56. [PMID: 31615708 DOI: 10.1016/j.bjoms.2019.08.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
39 Sweeny L, Zimmerman T, Carroll WR, Schmalbach CE, Day KE, Rosenthal EL. Head and Neck Cutaneous Squamous Cell Carcinoma Requiring Parotidectomy: Prognostic Indicators and Treatment Selection. Otolaryngol Head Neck Surg 2014;150:610-7. [DOI: 10.1177/0194599814520686] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
40 Bobin C, Ingrand P, Dréno B, Rio E, Malard O, Espitalier F. Prognostic factors for parotid metastasis of cutaneous squamous cell carcinoma of the head and neck. European Annals of Otorhinolaryngology, Head and Neck Diseases 2018;135:99-103. [DOI: 10.1016/j.anorl.2017.09.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
41 Veness MJ, Morgan GJ, Palme CE, Gebski V. Surgery and Adjuvant Radiotherapy in Patients with Cutaneous Head and Neck Squamous Cell Carcinoma Metastatic to Lymph Nodes: Combined Treatment Should be Considered Best Practice: . The Laryngoscope 2005;115:870-5. [DOI: 10.1097/01.mlg.0000158349.64337.ed] [Cited by in Crossref: 205] [Cited by in F6Publishing: 35] [Article Influence: 12.8] [Reference Citation Analysis]
42 Cracchiolo JR, Shaha AR. Parotidectomy for Parotid Cancer. Otolaryngol Clin North Am 2016;49:415-24. [PMID: 26895698 DOI: 10.1016/j.otc.2015.10.007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 3.6] [Reference Citation Analysis]
43 Fakhry N, Aldosari B, Michel J, Giorgi R, Collet C, Santini L, Giovanni A, Dessi P. Clinical and oncological outcomes after surgical excision of parotid gland tumours in patients aged over 80 years. International Journal of Oral and Maxillofacial Surgery 2013;42:1385-90. [DOI: 10.1016/j.ijom.2013.06.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
44 Califano JA, Lydiatt WM, Nehal KS, O’sullivan B, Schmults C, Seethala RR, Weber RS, Shah JP. Cutaneous Carcinoma of the Head and Neck. In: Amin MB, Edge SB, Greene FL, Byrd DR, Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR, Sullivan DC, Jessup JM, Brierley JD, Gaspar LE, Schilsky RL, Balch CM, Winchester DP, Asare EA, Madera M, Gress DM, Meyer LR, editors. AJCC Cancer Staging Manual. Cham: Springer International Publishing; 2017. pp. 171-81. [DOI: 10.1007/978-3-319-40618-3_15] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 3.6] [Reference Citation Analysis]
45 Cheng J, Yan S. Prognostic variables in high-risk cutaneous squamous cell carcinoma: a review. J Cutan Pathol 2016;43:994-1004. [PMID: 27404896 DOI: 10.1111/cup.12766] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
46 Košec A, Svetina L, Lukšić I. Significance of clinical stage, extent of surgery and outcome in cutaneous squamous cell carcinoma of the head and neck. Int J Oral Maxillofac Surg 2013;42:82-8. [PMID: 23137734 DOI: 10.1016/j.ijom.2012.10.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
47 . Carcinome épidermoïde cutané (carcinome spinocellulaire) : Recommandations de pratique clinique pour la prise en charge diagnostique et thérapeutique Argumentaire - Mai 2009. Annales de Dermatologie et de Vénéréologie 2009;136:S189-242. [DOI: 10.1016/s0151-9638(09)75172-5] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
48 Makki FM, Mendez AI, Taylor SM, Trites J, Bullock M, Flowerdew G, Hart RD. Prognostic factors for metastatic cutaneous squamous cell carcinoma of the parotid. J Otolaryngol Head Neck Surg 2013;42:14. [PMID: 23663562 DOI: 10.1186/1916-0216-42-14] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
49 Hinerman RW, Indelicato DJ, Amdur RJ, Morris CG, Werning JW, Vaysberg M, Kirwan J, Mendenhall WM. Cutaneous Squamous Cell Carcinoma Metastatic to Parotid-Area Lymph Nodes. Laryngoscope 2008;118:1989-96. [DOI: 10.1097/mlg.0b013e318180642b] [Cited by in Crossref: 71] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
50 Motaparthi K, Kapil JP, Velazquez EF. Cutaneous Squamous Cell Carcinoma: Review of the Eighth Edition of the American Joint Committee on Cancer Staging Guidelines, Prognostic Factors, and Histopathologic Variants. Adv Anat Pathol 2017;24:171-94. [PMID: 28590951 DOI: 10.1097/PAP.0000000000000157] [Cited by in Crossref: 32] [Cited by in F6Publishing: 14] [Article Influence: 10.7] [Reference Citation Analysis]
51 Bander TS, Nehal KS, Lee EH. Cutaneous Squamous Cell Carcinoma: Updates in Staging and Management. Dermatol Clin 2019;37:241-51. [PMID: 31084718 DOI: 10.1016/j.det.2019.03.009] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
52 Zhang J, Wang Y, Wijaya WA, Liang Z, Chen J. Efficacy and prognostic factors of adjuvant radiotherapy for cutaneous squamous cell carcinoma: A systematic review and meta-analysis. J Eur Acad Dermatol Venereol 2021;35:1777-87. [PMID: 33930213 DOI: 10.1111/jdv.17330] [Reference Citation Analysis]
53 Veness MJ. Time to rethink TNM staging in cutaneous SCC. Lancet Oncol 2008;9:702-3. [PMID: 18672208 DOI: 10.1016/S1470-2045(08)70185-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
54 Doescher J, Veit JA, Hoffmann TK. [The 8th edition of the AJCC Cancer Staging Manual : Updates in otorhinolaryngology, head and neck surgery]. HNO. 2017;65:956-961. [PMID: 28717958 DOI: 10.1007/s00106-017-0391-3] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 16.0] [Reference Citation Analysis]
55 van den Brekel MW, Castelijns JA. What the clinician wants to know: surgical perspective and ultrasound for lymph node imaging of the neck. Cancer Imaging 2005;5 Spec No A:S41-9. [PMID: 16361135 DOI: 10.1102/1470-7330.2005.0028] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
56 Dona E, Veness MJ, Cakir B, Morgan GJ. Metastatic cutaneous squamous cell carcinoma to the parotid: the role of surgery and adjuvant radiotherapy to achieve best outcome. ANZ J Surg. 2003;73:692-696. [PMID: 12956783 DOI: 10.1046/j.1445-2197.2003.02737.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 2.8] [Reference Citation Analysis]
57 Mcdowell LJ, Tan T, Bressel M, Estall V, Kleid S, Corry J, Johnston ML. Outcomes of cutaneous squamous cell carcinoma of the head and neck with parotid metastases. J Med Imaging Radiat Oncol 2016;60:668-76. [DOI: 10.1111/1754-9485.12484] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
58 Hasmat S, Ebrahimi A, Luk PP, Low T(, Mcdowell L, Magarey MJR, Veness M, Gupta R, Clark J. Positive survival trend in metastatic head and neck cutaneous squamous cell carcinoma over four‐decades: Multicenter study. Head & Neck 2019;41:3826-32. [DOI: 10.1002/hed.25912] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
59 Veness MJ, Porceddu S, Palme CE, Morgan GJ. Cutaneous head and neck squamous cell carcinoma metastatic to parotid and cervical lymph nodes. Head Neck. 2007;29:621-631. [PMID: 17230560 DOI: 10.1002/hed.20576] [Cited by in Crossref: 139] [Cited by in F6Publishing: 121] [Article Influence: 9.9] [Reference Citation Analysis]
60 Mokos M, Bašić-Jukić N. Parotid metastases of cutaneous squamous cell carcinoma in renal transplant recipients: Case series and literature review. Dermatol Ther 2021;34:e14907. [PMID: 33619803 DOI: 10.1111/dth.14907] [Reference Citation Analysis]
61 American Joint Committee on Cancer. Cutaneous Squamous Cell Carcinoma and Other Cutaneous Carcinomas. AJCC Cancer Staging Manual. New York: Springer; 2010. pp. 301-14. [DOI: 10.1007/978-0-387-88441-7_29] [Cited by in Crossref: 18] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
62 Iyer NG, Clark JR, Murali R, Gao K, O'brien CJ. Outcomes following parotidectomy for metastatic squamous cell carcinoma with microscopic residual disease: Implications for facial nerve preservation. Head Neck 2009;31:21-7. [DOI: 10.1002/hed.20912] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
63 Barnes L. Metastases to the head and neck: an overview. Head Neck Pathol 2009;3:217-24. [PMID: 20596975 DOI: 10.1007/s12105-009-0123-4] [Cited by in Crossref: 49] [Cited by in F6Publishing: 33] [Article Influence: 4.1] [Reference Citation Analysis]
64 Bonerandi JJ, Beauvillain C, Caquant L, Chassagne JF, Chaussade V, Clavère P, Desouches C, Garnier F, Grolleau JL, Grossin M, Jourdain A, Lemonnier JY, Maillard H, Ortonne N, Rio E, Simon E, Sei JF, Grob JJ, Martin L; French Dermatology Recommendations Association (aRED). Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma and precursor lesions. J Eur Acad Dermatol Venereol 2011;25 Suppl 5:1-51. [PMID: 22070399 DOI: 10.1111/j.1468-3083.2011.04296.x] [Cited by in F6Publishing: 64] [Reference Citation Analysis]
65 Mierzwa ML. Radiotherapy for Skin Cancers of the Face, Head, and Neck. Facial Plastic Surgery Clinics of North America 2019;27:131-8. [DOI: 10.1016/j.fsc.2018.08.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
66 Bejar C, Basset-seguin N, Faure F, Fieschi C, Frances C, Guenne C, Lebbe C, Peraldi M, Roux J, Lamas G, Maubec E. French ENT Society (SFORL) guidelines for the management of immunodeficient patients with head and neck cancer of cutaneous origin. European Annals of Otorhinolaryngology, Head and Neck Diseases 2014;131:121-9. [DOI: 10.1016/j.anorl.2014.02.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
67 Kreppel M, Krakowezki A, Kreppel B, Drebber U, Wedemeyer I, Mauch C, Zöller JE, Scheer M. Podoplanin expression in cutaneous head and neck squamous cell carcinoma-prognostic value and clinicopathologic implications: Podoplanin in Cutaneous Head Neck Cancer. J Surg Oncol 2013;107:376-83. [DOI: 10.1002/jso.23238] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
68 Wong WK, Morton RP. Elective management of cervical and parotid lymph nodes in stage N0 cutaneous squamous cell carcinoma of the head and neck: a decision analysis. Eur Arch Otorhinolaryngol 2014;271:3011-9. [DOI: 10.1007/s00405-013-2857-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
69 Schneider S, Kotowski U, Kadletz L, Brunner M, Stanisz I, Heiduschka G, Lill C. Intraparotid and cervical lymph nodes metastasis in primary parotid gland carcinoma—impact on clinical outcome. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 2020;129:570-4. [DOI: 10.1016/j.oooo.2020.01.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
70 Dinehart SM, Peterson S. Evaluation of the American Joint Committee on Cancer Staging System for Cutaneous Squamous Cell Carcinoma and Proposal of a New Staging System. Dermatologic Surgery 2005;31:1379-84. [DOI: 10.2310/6350.2005.31201] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
71 Penn R, Abemayor E, Nabili V, Bhuta S, Kirsch C. Perineural invasion detected by high-field 3.0-T magnetic resonance imaging. American Journal of Otolaryngology 2010;31:482-4. [DOI: 10.1016/j.amjoto.2009.07.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
72 Strom TJ, Caudell JJ, Harrison LB. Management of BCC and SCC of the Head and Neck. Cancer Control 2016;23:220-7. [DOI: 10.1177/107327481602300305] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
73 Flukes S, Long S, Lohia S, Barker CA, Dunn LA, Cracchiolo J, Ganly I, Patel S, Cohen MA. Metastatic Cutaneous Squamous Cell Carcinoma Involving the Parotid Gland: Experience Outside of the Sun Belt. OTO Open 2021;5:2473974X20984720. [PMID: 33474523 DOI: 10.1177/2473974X20984720] [Reference Citation Analysis]
74 Lubov J, Labbé M, Sioufi K, Morand GB, Hier MP, Khanna M, Sultanem K, Mlynarek AM. Prognostic factors of head and neck cutaneous squamous cell carcinoma: a systematic review. J Otolaryngol Head Neck Surg 2021;50:54. [PMID: 34493343 DOI: 10.1186/s40463-021-00529-7] [Reference Citation Analysis]
75 Kallini JR, Hamed N, Khachemoune A. Squamous cell carcinoma of the skin: epidemiology, classification, management, and novel trends. Int J Dermatol. 2015;54:130-140. [PMID: 25428226 DOI: 10.1111/ijd.12553] [Cited by in Crossref: 104] [Cited by in F6Publishing: 76] [Article Influence: 14.9] [Reference Citation Analysis]
76 McClure SA, Movahed R, Salama A, Ord RA. Maxillofacial metastases: a retrospective review of one institution's 15-year experience. J Oral Maxillofac Surg 2013;71:178-88. [PMID: 22705221 DOI: 10.1016/j.joms.2012.04.009] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
77 Watts F, Palme CE, Porceddu S, Sundaresan P, Clark JR, Gupta R. Clinician perspectives on the factors influencing prognostic stratification by the American Joint Commission on Cancer Head and Neck Cutaneous Squamous Cell Carcinoma Staging. Surgery 2021:S0039-6060(21)00344-5. [PMID: 34130810 DOI: 10.1016/j.surg.2021.04.019] [Reference Citation Analysis]
78 Brougham ND, Dennett ER, Cameron R, Tan ST. The incidence of metastasis from cutaneous squamous cell carcinoma and the impact of its risk factors: Cutaneous Squamous Cell Carcinoma Metastasis. J Surg Oncol 2012;106:811-5. [DOI: 10.1002/jso.23155] [Cited by in Crossref: 156] [Cited by in F6Publishing: 138] [Article Influence: 17.3] [Reference Citation Analysis]
79 Smith JA, Virk S, Palme CE, Low TH, Ch'ng S, Gupta R, Gao K, Clark J. Age is not a predictor of prognosis in metastatic cutaneous squamous cell carcinoma of the head and neck: Age is not a predictor of prognosis. ANZ Journal of Surgery 2018;88:E273-7. [DOI: 10.1111/ans.13757] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
80 Moore MG, Yueh B, Lin DT, Bradford CR, Smith RV, Khariwala SS. Controversies in the Workup and Surgical Management of Parotid Neoplasms. Otolaryngol Head Neck Surg 2021;164:27-36. [PMID: 32571148 DOI: 10.1177/0194599820932512] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
81 Cañueto J, Jaka A, Toll A. The Value of Adjuvant Radiotherapy in Cutaneous Squamous Cell Carcinoma: A Review. Actas Dermo-Sifiliográficas (English Edition) 2018;109:476-84. [DOI: 10.1016/j.adengl.2018.03.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
82 Daniels CP, Liu HY, Porceddu SV. Indications and limits of postoperative radiotherapy for skin malignancies. Curr Opin Otolaryngol Head Neck Surg 2021;29:100-6. [PMID: 33664195 DOI: 10.1097/MOO.0000000000000696] [Reference Citation Analysis]
83 Goh RY, Bova R, Fogarty GB. Cutaneous squamous cell carcinoma metastatic to parotid - analysis of prognostic factors and treatment outcome. World J Surg Oncol 2012;10:117. [PMID: 22731750 DOI: 10.1186/1477-7819-10-117] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
84 Czerwonka L, De Santis RJ, Horowitz G, Hong M, Orsini M, Enepekides D, Goldstein DP, Dort J, Higgins K. Staging cutaneous squamous cell carcinoma metastases to the parotid gland. Laryngoscope 2017;127:2063-9. [PMID: 28295401 DOI: 10.1002/lary.26544] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
85 Burton KA, Ashack KA, Khachemoune A. Cutaneous Squamous Cell Carcinoma: A Review of High-Risk and Metastatic Disease. Am J Clin Dermatol 2016;17:491-508. [PMID: 27358187 DOI: 10.1007/s40257-016-0207-3] [Cited by in Crossref: 114] [Cited by in F6Publishing: 115] [Article Influence: 28.5] [Reference Citation Analysis]
86 Martinez J, Cook JL. High-Risk Cutaneous Squamous Cell Carcinoma without Palpable Lymphadenopathy: Is There a Therapeutic Role for Elective Neck Dissection? Dermatol Surg 2007;33:410-20. [DOI: 10.1111/j.1524-4725.2007.33087.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 25] [Article Influence: 1.4] [Reference Citation Analysis]
87 Palyca P, Koshenkov VP, Mehnert JM. Developments in the treatment of locally advanced and metastatic squamous cell carcinoma of the skin: a rising unmet need. Am Soc Clin Oncol Educ Book 2014;:e397-404. [PMID: 24857130 DOI: 10.14694/EdBook_AM.2014.34.e397] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
88 Que SKT, Zwald FO, Schmults CD. Cutaneous squamous cell carcinoma: Incidence, risk factors, diagnosis, and staging. J Am Acad Dermatol. 2018;78:237-247. [PMID: 29332704 DOI: 10.1016/j.jaad.2017.08.059] [Cited by in Crossref: 176] [Cited by in F6Publishing: 160] [Article Influence: 58.7] [Reference Citation Analysis]
89 Ebrahimi A, Luk PP, Low H, McDowell L, Magarey MJR, Smith PN, Perriman DM, Veness M, Gupta R, Clark JR. A critical analysis of the 8th edition TNM staging for head and neck cutaneous squamous cell carcinoma with lymph node metastases and comparison to N1S3 stage and ITEM risk score: A multicenter study. J Surg Oncol 2021;123:1531-9. [PMID: 33721339 DOI: 10.1002/jso.26410] [Reference Citation Analysis]
90 Creighton F, Lin A, Leavitt E, Lin D, Deschler D, Emerick K. Factors affecting survival and locoregional control in head and neck cSCCA with nodal metastasis. The Laryngoscope 2017;128:1881-6. [DOI: 10.1002/lary.27048] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
91 American Joint Committee On Cancer. Cutaneous Squamous Cell Carcinoma and Other Cutaneous Carcinomas. AJCC Cancer Staging Handbook. New York: Springer; 2010. pp. 359-76. [DOI: 10.1007/978-0-387-88443-1_29] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
92 Swendseid BP, Philips RHW, Rao NK, Goldman RA, Luginbuhl AJ, Curry JM, Keane WM, Cognetti DM. The underappreciated role of auriculotemporal nerve involvement in local failure following parotidectomy for cancer. Head Neck 2020;42:3253-62. [PMID: 32686885 DOI: 10.1002/hed.26372] [Reference Citation Analysis]
93 de Boer E, Moore LS, Warram JM, Huang CC, Brandwein-Gensler MS, van Dam GM, Rosenthal EL, Schmalbach CE. On the horizon: Optical imaging for cutaneous squamous cell carcinoma. Head Neck 2016;38 Suppl 1:E2204-13. [PMID: 25899874 DOI: 10.1002/hed.24079] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
94 Rotman A, Kerr SJ, Giddings CEB. Elective neck dissection in metastatic cutaneous squamous cell carcinoma to the parotid gland: A systematic review and meta‐analysis. Head & Neck 2018;41:1131-9. [DOI: 10.1002/hed.25561] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
95 Harris BN, Bayoumi A, Rao S, Moore MG, Farwell DG, Bewley AF. Factors Associated with Recurrence and Regional Adenopathy for Head and Neck Cutaneous Squamous Cell Carcinoma. Otolaryngol Head Neck Surg 2017;156:863-9. [DOI: 10.1177/0194599817697053] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
96 O'hara J, Ferlito A, Takes RP, Rinaldo A, Strojan P, Shaha AR, Rodrigo JP, Paleri V, Eisele DW. Cutaneous squamous cell carcinoma of the head and neck metastasizing to the parotid gland-A review of current recommendations. Head Neck 2011;33:1789-95. [DOI: 10.1002/hed.21583] [Cited by in Crossref: 51] [Cited by in F6Publishing: 41] [Article Influence: 4.6] [Reference Citation Analysis]
97 Howle JR, Morgan GJ, Kalnins I, Palme CE, Veness MJ. METASTATIC CUTANEOUS SQUAMOUS CELL CARCINOMA OF THE SCALP. ANZ J Surg 2008;78:449-53. [DOI: 10.1111/j.1445-2197.2008.04533.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
98 Hirshoren N, Danne J, Dixon BJ, Magarey M, Kleid S, Webb A, Tiong A, Corry J, Gyorki D. Prognostic markers in metastatic cutaneous squamous cell carcinoma of the head and neck. Head Neck 2017;39:772-8. [PMID: 28199044 DOI: 10.1002/hed.24683] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
99 Anderson S, Patel P, Panizza B. Squamous Cell Carcinoma Extending to the Temporal Bone. In: Riffat F, Palme CE, Veness M, editors. Non-melanoma Skin Cancer of the Head and Neck. New Delhi: Springer India; 2015. pp. 131-43. [DOI: 10.1007/978-81-322-2497-6_10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
100 Marrazzo G, Thorpe R, Condie D, Pinho MC, Srivastava D. Clinical and Pathologic Factors Predictive of Positive Radiologic Findings in High-Risk Cutaneous Squamous Cell Carcinoma. Dermatol Surg 2015;41:1405-10. [PMID: 26517320 DOI: 10.1097/DSS.0000000000000526] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
101 Yesensky J, Solis RN, Bewley A. Facial Nerve Sacrifice During Parotidectomy for Metastatic Cutaneous Squamous Cell Carcinoma. OTO Open 2021;5:2473974X21996627. [PMID: 33718752 DOI: 10.1177/2473974X21996627] [Reference Citation Analysis]
102 Teymoortash A, Schultz ES, Werner JA. [Significance of parotid metastases of squamous cell carcinoma of scalp]. Hautarzt 2007;58:323-7. [PMID: 17237930 DOI: 10.1007/s00105-006-1275-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
103 Palme CE, Mackay SG, Kalnins I, Morgan GJ, Veness MJ. The need for a better prognostic staging system in patients with metastatic cutaneous squamous cell carcinoma of the head and neck. Current Opinion in Otolaryngology & Head & Neck Surgery 2007;15:103-6. [DOI: 10.1097/moo.0b013e3280586723] [Cited by in Crossref: 19] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
104 Clark JR, Rumcheva P, Veness MJ. Analysis and Comparison of the 7th Edition American Joint Committee on Cancer (AJCC) Nodal Staging System for Metastatic Cutaneous Squamous Cell Carcinoma of the Head and Neck. Ann Surg Oncol 2012;19:4252-8. [DOI: 10.1245/s10434-012-2504-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
105 Dean NR, Sweeny L, Magnuson JS, Carroll WR, Robinson D, Desmond RA, Rosenthal EL. Outcomes of recurrent head and neck cutaneous squamous cell carcinoma. J Skin Cancer 2011;2011:972497. [PMID: 21773040 DOI: 10.1155/2011/972497] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
106 Givi B, Andersen PE, Diggs BS, Wax MK, Gross ND. Outcome of patients treated surgically for lymph node metastases from cutaneous squamous cell carcinoma of the head and neck. Head Neck 2011;33:999-1004. [DOI: 10.1002/hed.21574] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 5.0] [Reference Citation Analysis]
107 Mcdowell L, Yom SS. Locally advanced non-melanomatous skin cancer: Contemporary radiotherapeutic management. Oral Oncology 2019;99:104443. [DOI: 10.1016/j.oraloncology.2019.104443] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
108 DeCesaris C, Amin NP, Hundal J, Vujaskovic Z, Agarwal M. Hyperthermia and Hyper-fractionated Radiation for a Cutaneous Squamous Cell Carcinoma Progressing on Standard Therapy: A Case Report. Adv Radiat Oncol 2019;4:4-9. [PMID: 30706002 DOI: 10.1016/j.adro.2018.07.010] [Reference Citation Analysis]
109 Farasat S, Yu SS, Neel VA, Nehal KS, Lardaro T, Mihm MC, Byrd DR, Balch CM, Califano JA, Chuang AY, Sharfman WH, Shah JP, Nghiem P, Otley CC, Tufaro AP, Johnson TM, Sober AJ, Liégeois NJ. A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: creation and rationale for inclusion of tumor (T) characteristics. J Am Acad Dermatol 2011;64:1051-9. [PMID: 21255868 DOI: 10.1016/j.jaad.2010.08.033] [Cited by in Crossref: 157] [Cited by in F6Publishing: 122] [Article Influence: 15.7] [Reference Citation Analysis]
110 Babington S, Veness MJ, Cakir B, Gebski VJ, Morgan GJ. Squamous cell carcinoma of the lip: is there a role for adjuvant radiotherapy in improving local control following incomplete or inadequate excision? ANZ J Surg 2003;73:621-5. [PMID: 12887533 DOI: 10.1046/j.1445-2197.2003.t01-1-02710.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
111 Maydan E, Desciak EB, Eliezri YD. Management of cutaneous neoplasms invading the parotid gland. Dermatol Surg 2006;32:1209-13. [PMID: 16970708 DOI: 10.1111/j.1524-4725.2006.32268.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
112 Amoils M, Kim J, Lee C, Sunwoo JB, Colevas AD, Aasi SZ, Hollmig ST, Ma Y, Divi V. PD-L1 Expression and Tumor-Infiltrating Lymphocytes in High-Risk and Metastatic Cutaneous Squamous Cell Carcinoma. Otolaryngol Head Neck Surg 2019;160:93-9. [PMID: 30012051 DOI: 10.1177/0194599818788057] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
113 Gandolfi MM, Slattery W 3rd. Parotid Gland Tumors and the Facial Nerve. Otolaryngol Clin North Am 2016;49:425-34. [PMID: 27040587 DOI: 10.1016/j.otc.2015.12.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
114 Wu J, Fang Q, Liu F, Zhang X. Intraparotid node metastases in adults with parotid mucoepidermoid cancer: an indicator of prognosis? British Journal of Oral and Maxillofacial Surgery 2020;58:525-9. [DOI: 10.1016/j.bjoms.2019.10.323] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
115 Lombardi D, Tomasoni M, Paderno A, Mattavelli D, Ferrari M, Battocchio S, Missale F, Mazzola F, Peretti G, Mocellin D, Borsetto D, Fussey JM, Nankivell P, Skalidi N, Bussi M, Giordano L, Galli A, Arrigoni G, Raffetti E, Pracy P, Vander Poorten V, Nicolai P. The impact of nodal status in major salivary gland carcinoma: A multicenter experience and proposal of a novel N-classification. Oral Oncol 2021;112:105076. [PMID: 33137587 DOI: 10.1016/j.oraloncology.2020.105076] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
116 Pramana A, Browne L, Graham PH. Metastatic cutaneous squamous cell carcinoma to parotid nodes: the role of bolus with adjuvant radiotherapy. J Med Imaging Radiat Oncol 2012;56:100-8. [PMID: 22339753 DOI: 10.1111/j.1754-9485.2011.02326.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
117 Porceddu SV, Daniels C, Yom SS, Liu H, Waldron J, Gregoire V, Moore A, Veness M, Yao M, Johansen J, Mehanna H, Rischin D, Le QT. Head and Neck Cancer International Group (HNCIG) Consensus Guidelines for the Delivery of Postoperative Radiation Therapy in Complex Cutaneous Squamous Cell Carcinoma of the Head and Neck (cSCCHN). Int J Radiat Oncol Biol Phys 2020;107:641-51. [PMID: 32289475 DOI: 10.1016/j.ijrobp.2020.03.024] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
118 Moore BA, Weber RS, Prieto V, El-Naggar A, Holsinger FC, Zhou X, Lee JJ, Lippman S, Clayman GL. Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck. Laryngoscope 2005;115:1561-7. [PMID: 16148695 DOI: 10.1097/01.mlg.0000173202.56739.9f] [Cited by in Crossref: 199] [Cited by in F6Publishing: 167] [Article Influence: 12.4] [Reference Citation Analysis]
119 Meyer MF, Wolber P, Arolt C, Wessel M, Quaas A, Lang S, Klussmann JP, Semrau R, Beutner D. Survival after parotid gland metastases of cutaneous squamous cell carcinoma of the head and neck. Oral Maxillofac Surg 2021;25:383-8. [PMID: 33400041 DOI: 10.1007/s10006-020-00934-8] [Reference Citation Analysis]
120 Hirshoren N, Ruskin O, Mcdowell LJ, Magarey M, Kleid S, Dixon BJ. Management of Parotid Metastatic Cutaneous Squamous Cell Carcinoma: Regional Recurrence Rates and Survival. Otolaryngol Head Neck Surg 2018;159:293-9. [DOI: 10.1177/0194599818764348] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
121 Zeidan YH, Zauls AJ, Bilic M, Lentsch EJ, Sharma AK. Treatment of eccrine porocarcinoma with metastasis to the parotid gland using intensity-modulated radiation therapy: a case report. J Med Case Rep 2010;4:147. [PMID: 20492705 DOI: 10.1186/1752-1947-4-147] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
122 Girardi FM, Wagner VP, Martins MD, Abentroth AL, Hauth LA. Better outcome for parotid versus neck metastasis of head and neck cutaneous squamous cell carcinoma: a new report on reemerging data. Braz J Otorhinolaryngol 2021;87:389-95. [PMID: 31870740 DOI: 10.1016/j.bjorl.2019.10.007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
123 Lai SY, Weber RS. High-risk non-melanoma skin cancer of the head and neck. Curr Oncol Rep 2005;7:154-8. [PMID: 15717950 DOI: 10.1007/s11912-005-0042-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
124 Gurudutt VV, Genden EM. Cutaneous squamous cell carcinoma of the head and neck. J Skin Cancer 2011;2011:502723. [PMID: 21461387 DOI: 10.1155/2011/502723] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 3.6] [Reference Citation Analysis]
125 Chen AM, Grekin RC, Garcia J, Bucci MK, Margolis LW. Radiation Therapy for Cutaneous Squamous Cell Carcinoma Involving the Parotid Area Lymph Nodes: Dose and Volume Considerations. International Journal of Radiation Oncology*Biology*Physics 2007;69:1377-80. [DOI: 10.1016/j.ijrobp.2007.05.005] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
126 Skulsky SL, O'sullivan B, Mcardle O, Leader M, Roche M, Conlon PJ, O'neill JP, W. Eisele D. Review of high‐risk features of cutaneous squamous cell carcinoma and discrepancies between the American Joint Committee on Cancer and NCCN Clinical Practice Guidelines In Oncology. Head Neck 2017;39:578-94. [DOI: 10.1002/hed.24580] [Cited by in Crossref: 56] [Cited by in F6Publishing: 50] [Article Influence: 11.2] [Reference Citation Analysis]
127 Nisa L, Salmina C, Dettmer MS, Arnold A, Aebersold DM, Borner U, Giger R. Implications of intraglandular lymph node metastases in primary carcinomas of the parotid gland: Intraglandular Metastases in PGCs. The Laryngoscope 2015;125:2099-106. [DOI: 10.1002/lary.25342] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
128 Ryan WR, Heaton CM, Wang SJ. Elective regional lymphadenectomy for advanced auricular squamous cell carcinoma. World J Otorhinolaryngol 2013; 3(1): 16-21 [DOI: 10.5319/wjo.v3.i1.16] [Reference Citation Analysis]
129 Veness MJ, Kian Ang K. Cutaneous Carcinoma. Clinical Radiation Oncology. Elsevier; 2012. pp. 757-69. [DOI: 10.1016/b978-1-4377-1637-5.00039-0] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
130 McLean T, Brunner M, Ebrahimi A, Gao K, Ch'ng S, Veness MJ, Clark JR. Concurrent primary and metastatic cutaneous head and neck squamous cell carcinoma: Analysis of prognostic factors. Head Neck 2013;35:1144-8. [PMID: 22907905 DOI: 10.1002/hed.23102] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
131 Lu SM, Lien WW. Concurrent Radiotherapy With Cetuximab or Platinum-based Chemotherapy for Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck. American Journal of Clinical Oncology 2018;41:95-9. [DOI: 10.1097/coc.0000000000000228] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
132 Gurney B, Newlands C. Management of regional metastatic disease in head and neck cutaneous malignancy. 1. Cutaneous squamous cell carcinoma. Br J Oral Maxillofac Surg 2014;52:294-300. [PMID: 24559975 DOI: 10.1016/j.bjoms.2014.01.015] [Cited by in Crossref: 35] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
133 Sood A, Wykes J, Roshan D, Wang LY, Mcguinness J, Fowler A, Ebrahimi A. A critical analysis of the prognostic performance of the 8th edition American Joint Committee on Cancer staging for metastatic cutaneous squamous cell carcinoma of the head and neck. Head & Neck 2019;41:1591-6. [DOI: 10.1002/hed.25599] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
134 Herman MP, Amdur RJ, Werning JW, Dziegielewski P, Morris CG, Mendenhall WM. Elective neck management for squamous cell carcinoma metastatic to the parotid area lymph nodes. Eur Arch Otorhinolaryngol 2016;273:3875-9. [DOI: 10.1007/s00405-016-4021-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
135 Fussey J, Tomasoni M, Tirelli G, Giordano L, Galli A, Colangeli R, Cazzador D, Tofanelli M, Da Mosto MC, Bianchini C, Pelucchi S, Ubayasiri K, Elsayed M, Long P, Saratziotis A, Hajiioannou J, Piazza C, Deganello A, Lombardi D, Nicolai P, Pracy P, Sharma N, Nankivell P, Borsetto D, Boscolo-Rizzo P. Prognostic indicators in clinically node-negative malignant primary salivary tumours of the parotid: A multicentre experience. Oral Oncol 2021;123:105577. [PMID: 34742011 DOI: 10.1016/j.oraloncology.2021.105577] [Reference Citation Analysis]
136 Park SW, Eade T, Pang L, Wignall A, Veivers D. Role of neck dissection in metastatic squamous cell carcinoma to the parotid gland. J Laryngol Otol. 2016;130 Suppl 4:S54-S59. [PMID: 27488339 DOI: 10.1017/s0022215116008343] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
137 Ch'ng S, Maitra A, Allison RS, Chaplin JM, Gregor RT, Lea R, Tan ST. Parotid and cervical nodal status predict prognosis for patients with head and neck metastatic cutaneous squamous cell carcinoma. J Surg Oncol 2008;98:101-5. [PMID: 18523982 DOI: 10.1002/jso.21092] [Cited by in Crossref: 69] [Cited by in F6Publishing: 60] [Article Influence: 5.3] [Reference Citation Analysis]
138 Cañueto J, Román-curto C. Los nuevos sistemas de estadificación del AJCC incorporan novedades en el cáncer cutáneo. Actas Dermo-Sifiliográficas 2017;108:818-26. [DOI: 10.1016/j.ad.2017.05.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
139 Casswell G, Cavanagh K, Ravi Kumar AS, Giddings C, Mcdowell L. Setting the stage: Contemporary staging of non-melanomatous skin cancer and implementation of the new American Joint Committee on cancer eighth edition staging manual. Oral Oncology 2019;98:102-8. [DOI: 10.1016/j.oraloncology.2019.09.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
140 Nuño-gonzález A, Vicente-martín F, Pinedo-moraleda F, López-estebaranz J. Carcinoma epidermoide cutáneo de alto riesgo. Actas Dermo-Sifiliográficas 2012;103:567-78. [DOI: 10.1016/j.ad.2011.09.005] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
141 Knopf A, Szyper M, Mansour N, Sonnenberg J, Hofauer B, Niedermeyer H. A critical review of 20 years of parotid gland surgery. Acta Otolaryngol 2016;136:711-6. [PMID: 26986955 DOI: 10.3109/00016489.2016.1153808] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
142 Ahmed MM, Moore BA, Schmalbach CE. Utility of head and neck cutaneous squamous cell carcinoma sentinel node biopsy: a systematic review. Otolaryngol Head Neck Surg 2014;150:180-7. [PMID: 24201060 DOI: 10.1177/0194599813511949] [Cited by in Crossref: 55] [Cited by in F6Publishing: 43] [Article Influence: 6.9] [Reference Citation Analysis]
143 Audet N, Palme CE, Gullane PJ, Gilbert RW, Brown DH, Irish J, Neligan P. Cutaneous metastatic squamous cell carcinoma to the parotid gland: analysis and outcome. Head Neck. 2004;26:727-732. [PMID: 15287040 DOI: 10.1002/hed.20048] [Cited by in Crossref: 84] [Cited by in F6Publishing: 73] [Article Influence: 5.3] [Reference Citation Analysis]
144 Li Y, Lu T, Hu G. Gene sequencing and expression of Raf-1 in lymphatic metastasis of hypopharyngeal carcinoma. Cancer Biomark 2020;28:181-91. [PMID: 32224526 DOI: 10.3233/CBM-191238] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
145 D'souza J, Clark J. Management of the neck in metastatic cutaneous squamous cell carcinoma of the head and neck. Current Opinion in Otolaryngology & Head & Neck Surgery 2011;19:99-105. [DOI: 10.1097/moo.0b013e328343e811] [Cited by in Crossref: 43] [Cited by in F6Publishing: 6] [Article Influence: 4.3] [Reference Citation Analysis]
146 Lee KC, Moon WK, Chung JW, Choi SH, Cho N, Cha JH, Lee EH, Kim SM, Kim HS, Han MH, Chang KH. Assessment of lymph node metastases by contrast-enhanced MR imaging in a head and neck cancer model. Korean J Radiol 2007;8:9-14. [PMID: 17277558 DOI: 10.3348/kjr.2007.8.1.9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
147 Scurry WC, Isaacson JE, Fedok FG. New-onset facial paralysis and undiagnosed recurrence of cutaneous malignancy: evaluation and management. American Journal of Otolaryngology 2006;27:139-42. [DOI: 10.1016/j.amjoto.2005.07.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
148 Veness MJ, Palme CE, Smith M, Cakir B, Morgan GJ, Kalnins I. Cutaneous head and neck squamous cell carcinoma metastatic to cervical lymph nodes (nonparotid): A better outcome with surgery and adjuvant radiotherapy. The Laryngoscope 2003;113:1827-33. [DOI: 10.1097/00005537-200310000-00031] [Cited by in Crossref: 96] [Cited by in F6Publishing: 82] [Article Influence: 8.7] [Reference Citation Analysis]
149 Yilmaz M, Eskiizmir G, Friedman O. Cutaneous Squamous Cell Carcinoma of the Head and Neck. Facial Plastic Surgery Clinics of North America 2012;20:473-81. [DOI: 10.1016/j.fsc.2012.07.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
150 Southwell KE, Chaplin JM, Eisenberg RL, Mcivor NP, Morton RP. Effect of immunocompromise on metastatic cutaneous squamous cell carcinoma in the parotid and neck. Head Neck 2006;28:244-8. [DOI: 10.1002/hed.20321] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
151 Soffer JM, Nassif SJ, Von Plato M, Chisholm J, O'Leary MA. Survival and prognostic factors of salivary gland malignant mixed tumor-not otherwise specified: A population-based analysis. Am J Otolaryngol 2021;42:103135. [PMID: 34171696 DOI: 10.1016/j.amjoto.2021.103135] [Reference Citation Analysis]
152 Sood A, Wykes J, McGuinness J, Fowler A, Ebrahimi A. Nodal metastasis size predicts disease-free survival in cutaneous head and neck squamous cell carcinoma involving the parotid but not cervical nodes. ANZ J Surg 2020;90:2537-42. [PMID: 33176051 DOI: 10.1111/ans.16413] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
153 Talmi YP. Problems in the current TNM staging of nonmelanoma skin cancer of the head and neck. Head Neck 2007;29:525-7. [DOI: 10.1002/hed.20599] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
154 Mclaughlin EJ, Miller L, Shin TM, Sobanko JF, Cannady SB, Miller CJ, Newman JG. Rate of regional nodal metastases of cutaneous squamous cell carcinoma in the immunosuppressed patient. American Journal of Otolaryngology 2017;38:325-8. [DOI: 10.1016/j.amjoto.2017.01.035] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
155 Andruchow JL, Veness MJ, Morgan GJ, Gao K, Clifford A, Shannon KF, Poulsen M, Kenny L, Palme CE, Gullane P, Morris C, Mendenhall WM, Patel KN, Shah JP, O'brien CJ. Implications for clinical staging of metastatic cutaneous squamous carcinoma of the head and neck based on a multicenter study of treatment outcomes. Cancer 2006;106:1078-83. [DOI: 10.1002/cncr.21698] [Cited by in Crossref: 115] [Cited by in F6Publishing: 95] [Article Influence: 7.7] [Reference Citation Analysis]
156 Porceddu SV, Bressel M, Poulsen MG, Stoneley A, Veness MJ, Kenny LM, Wratten C, Corry J, Cooper S, Fogarty GB, Collins M, Collins MK, Macann AMJ, Milross CG, Penniment MG, Liu HY, King MT, Panizza BJ, Rischin D. Postoperative Concurrent Chemoradiotherapy Versus Postoperative Radiotherapy in High-Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck: The Randomized Phase III TROG 05.01 Trial. JCO 2018;36:1275-83. [DOI: 10.1200/jco.2017.77.0941] [Cited by in Crossref: 79] [Cited by in F6Publishing: 18] [Article Influence: 26.3] [Reference Citation Analysis]
157 Grammatica A, Tomasoni M, Fior M, Ulaj E, Gualtieri T, Bossi P, Battocchio S, Lombardi D, Deganello A, Mattavelli D, Nicolai P, Girardi F, Piazza C. Regional disease in head and neck cutaneous squamous cell carcinoma: the role of primary tumor characteristics and number of nodal metastases. Eur Arch Otorhinolaryngol 2021. [PMID: 34170382 DOI: 10.1007/s00405-021-06944-w] [Reference Citation Analysis]
158 Teymoortash A, Werner JA. Current advances in diagnosis and surgical treatment of lymph node metastasis in head and neck cancer. GMS Curr Top Otorhinolaryngol Head Neck Surg 2012;11:Doc04. [PMID: 23320056 DOI: 10.3205/cto000086] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
159 Moeckelmann N, Ebrahimi A, Dirven R, Liu J, Low T, Gupta R, Ashford B, Ch’ng S, Palme CE, Clark JR. Analysis and Comparison of the 8th Edition American Joint Committee on Cancer (AJCC) Nodal Staging System in Cutaneous and Oral Squamous Cell Cancer of the Head and Neck. Ann Surg Oncol 2018;25:1730-6. [DOI: 10.1245/s10434-018-6340-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 8.3] [Reference Citation Analysis]
160 Guntinas-Lichius O, Thielker J, Robbins KT, Olsen KD, Shaha AR, Mäkitie AA, de Bree R, Vander Poorten V, Quer M, Rinaldo A, Kowalski LP, Rodrigo JP, Hamoir M, Ferlito A. Prognostic role of intraparotid lymph node metastasis in primary parotid cancer: Systematic review. Head Neck 2021;43:997-1008. [PMID: 33169420 DOI: 10.1002/hed.26541] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
161 Nuño-gonzález A, Vicente-martín F, Pinedo-moraleda F, López-estebaranz J. High-Risk Cutaneous Squamous Cell Carcinoma. Actas Dermo-Sifiliográficas (English Edition) 2012;103:567-78. [DOI: 10.1016/j.adengl.2012.08.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]